Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...

Class 10 English Error Correction Exercise: The CBSE Class 10 English exam includes a dedicated section of grammar questions that carry high weightage. Among them ...

AstraZeneca has begun a new agreement with Daiichi Sankyo to develop and market an antibody to treat cancer, worth up to $6 billion. The deal covers DS-1062, Daiichi Sankyo’s proprietary antibody-drug ...

I'm currently using AWS ec2. Since I want to resume the log of training a deep learning model (which means that I train a single deep learning model, stop in the middle and then resume training), I ...